MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Myoclonus: Etiology and Pathogenesis"

  • 2023 International Congress

    Opsoclonus Myoclonus Syndrome due to subdural hematoma: an uncommon etiology

    V. Arca, F. Cavalcante, M. Saraiva, M. Bezerra (Recife, Brazil)

    Objective: . Background: Introduction:Opsoclonus myoclonus syndrome is characterized by myoclonic jerks and ocular opsoclonus (spontaneous, arrhythmic, and conjugate ocular saccades that occur in all directions…
  • 2022 International Congress

    Opsoclonus-Myoclonus Syndrome in Subacute Sclerosing Panencephalitis: Antibodies and Cytokine Response

    D. Labunskiy, S. Kiryukhina, V. Podsevatkin (Saransk, Russian Federation)

    Objective: Since the treatment of  subacute sclerosing panencephalitis (SSPE)  is difficult and prognosis if often fatal and therapy is problematic the goal of this research was…
  • 2022 International Congress

    ACUTE MOVEMENT DISORDERS: A NEW ASPECT OF SARS-COV2 INFECTION IN CHILDREN

    M. Ben Hafsa (Tunis, Tunisia)

    Objective: To analyze the clinical aspects, radiological features and evolution of COVID-19-associated movement disorders (MD) in children and adolescents. Background: During the 5th wave of…
  • 2022 International Congress

    Myoclonus in a Large Urban Center: 10 Year Experience

    K. Oh, M. Hamed, H. Sarva, D. Victor (New York, USA)

    Objective: To describe various forms of myoclonus in admitted patients in a 10-year period. Background: Myoclonus consists of brief, shock-like involuntary movements. It may occur…
  • 2022 International Congress

    Secondary generalized myoclonus resulting from brainstem ischemic lesion

    S. Saaf, A. Miqdadi, S. Lhassani, M. Hakimi, J. Aasfara, A. Hazim (Casablanca, Morocco)

    Objective: To report the case of a patient who developed generalized myoclonus revealing ischemic lesions of the brainstem Background: Myoclonus is a movement disorder defined…
  • MDS Virtual Congress 2021

    SARS-CoV-2 Encephalopathy Presenting as Opsoclonus Myoclonus Syndrome Successfully Treated with IV Immunoglobulins

    M. Salgado, I. Hacker, A. Alport, J. Ma (Brooklyn, USA)

    Objective: To present a case of a SARS-CoV-2 patient presenting with opsoclonus myoclonus syndrome who was successfully treated with IVIGs. Background: The COVID-19 pandemic has…
  • MDS Virtual Congress 2021

    Covid-19 associated Opsoclonus-Myoclonus Syndrome with encephalopathy

    A. Tageldin, L. White, M. Ellul, V. Bharambe, B. Michael, M. Bonello, S. Alusi (Southport, United Kingdom)

    Objective: To investigate whether the encephalopathy associated with the opsioclonus myoclonus syndrome in COVID-19 is likely to be parainfections. Background: Adult onset opsoclonus myoclonus syndrome…
  • MDS Virtual Congress 2021

    Lingual myoclonus associated with brain metastasis located near the primary tongue motor cortex: case report.

    G. Velilla Alonso, J. Soto Alsar, JJ. Rodríguez Irausquin, A. Sánchez Soblechero (Madrid, Spain)

    Objective: To report a case of a patient with lung cancer who developed lingual myoclonus, revealing brain metastases. Background: Lingual myoclonus has been described associated…
  • MDS Virtual Congress 2021

    Spectrum of Movement Disorders among Children with Subacute Sclerosing Panencephalitis (SSPE): A Cross-sectional Study

    D. Garg, V. Kakkar, D. Kapoor, S. Sharma, S. Mukherjee, H. Pemde (New Delhi, India)

    Objective: We aimed to assess spectrum of movement disorders associated with pediatric SSPE. Background: Subacute sclerosing panencephalitis (SSPE) is a rare neurodegenerative disorder due to…
  • MDS Virtual Congress 2021

    Gabapentin-induced severe myoclonus in a patient with impaired renal function

    M. Akkari, M. Messelmani, H. Derbali, M. Mansour, A. Riahi, I. Bedoui, J. Zaouali, R. Mrissa (Tunis, Tunisia)

    Objective: The aim of this study was to present myoclonus as a reversible side effect of gabapentin in order to bring this trend to clinician’s…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley